Follow-up to Danya Cebus: the Dividend Continues, but Short-Term Credit Funds the Proof Year
Danya Cebus kept approving NIS 40 million quarterly dividends while operating cash flow remained negative and the Blue Line required fresh project equity. Q1 does not point to immediate liquidity stress, but it turns the dividend from a confidence signal into a funding test.
What started at the end of 2025 as a yellow flag around capital allocation became a live funding test in Q1 2026. Danya Cebus paid a NIS 40 million dividend in January, approved another NIS 40 million dividend in March that was paid in May, and approved another NIS 40 million distribution after the balance-sheet date. At the same time, operating cash flow remained negative at NIS 41.7 million, and the Jerusalem Blue Line required a NIS 118.2 million injection into investee companies. The funding came mainly from a NIS 181.0 million increase in short-term credit, just as working capital and the current ratio declined. This is not an immediate liquidity-stress picture: the company ended March with NIS 316.8 million of cash, and the broader liquidity layer, including restricted deposits and marketable collateral, was about NIS 526 million. But the burden of proof has changed: the dividend is no longer only a board confidence signal, it is a commitment that the next quarters need to cover with operating cash and longer project funding, not with more short-term credit.
The dividend is now a funding test, not only a policy signal
The NIS 40 million quarterly dividend looks consistent, but this quarter makes the cash cost of that consistency clearer. Net profit was NIS 40.5 million, almost the same size as the dividend paid in January. On an accounting-profit basis, the distribution does not look unusual. On a cash basis, it comes while the operating business has still not put money back into the account.
That gap is the point of this follow-up. Operating cash flow was negative NIS 41.7 million, much better than the negative NIS 217.9 million in the comparable quarter, but still negative. The improvement is real, yet it still does not cover even the quarterly distribution. In addition, the company approved another NIS 40 million dividend during the quarter, paid in May, and approved another dividend of the same size on May 19. The dividend sequence continued before Q1 showed positive operating cash flow.
The buyback program sharpens the distinction. The board renewed a buyback plan of up to NIS 50 million, but no shares had been purchased by the report date. The real cash use in the quarter was not the buyback. It was the dividend and project funding. The buyback is currently a message. The dividend is cash that has already gone out or has been approved to go out.
The Blue Line turned short-term credit into the active bridge
The all-in cash view here checks what happened after actual cash uses: operating activity, investments, injections into investee companies, dividends, repayment of loans and lease liabilities, and interest. The NIS 18.7 million line combines loan repayment and lease liabilities, so the correct treatment here is to leave it as one cash-use line rather than isolate a lease component.
| Q1 cash layer | Amount | Meaning |
|---|---|---|
| Operating cash flow | NIS 41.7 million outflow | The business still consumed cash, despite improvement versus the comparable quarter |
| Investing cash flow | NIS 147.6 million outflow | The main use was a NIS 118.2 million injection into investee companies |
| Change in short-term credit | NIS 181.0 million inflow | The central funding source of the quarter |
| Dividend paid | NIS 40.0 million outflow | A real distribution during a quarter with negative operating cash flow |
| Repayment of loans and lease liabilities | NIS 18.7 million outflow | Another cash use, not separately split between debt and leases |
| Cash at quarter end | NIS 316.8 million | Down from NIS 384.3 million at the start of the year |
The number that ties the table together is the NIS 181 million of short-term credit. The company explains that the credit was taken for an investment in an associate, and that investment is tied to the equity required for the Jerusalem Blue Line project. In other words, the Blue Line has moved from a strategic backlog item into a cash demand that is already activating short-term credit.
The company also states where it is preparing to go next: expanding short-term credit facilities to about NIS 400 million, while examining dedicated long-term credit for specific projects. That wording matters because it defines the bridge period. As long as the funding sits mostly in short-term credit, the dividend competes with PPP projects for the same financial flexibility. If dedicated long-term credit replaces part of that layer, Q1 will look more like a reasonable bridge-financing quarter and less like evidence of persistent pressure.
There is no liquidity stress yet, but the margin for error narrowed
The balance sheet still gives the company time. Equity stood at NIS 902.9 million at the end of March, working capital remained positive, and the broader liquidity layer of about NIS 526 million is not an empty-cash-box picture. Net profit was also similar in size to the quarterly dividend, so the counter-thesis is reasonable: the company may simply be funding a heavy construction phase in a large project while the distribution rests on existing profitability and adequate liquidity.
Still, the quarter weakened the important margins of safety. Working capital fell from NIS 482.8 million at the end of 2025 to NIS 340.5 million, and the current ratio declined from 1.24 to 1.16. Current liabilities rose to 63% of total funding sources, from 61% at the end of 2025. These numbers do not settle the argument alone, but they show that the proof year is being financed through the short-term side of the balance sheet.
The next proof is replacing bridge credit with operating cash
The current conclusion is not that the dividend is already dangerous. The conclusion is that the distribution has become a quality test for cash flow: if operating cash flow turns positive in the next few quarters, and if dedicated project credit replaces part of the short-term credit, the dividend sequence will look like stable policy from a company with enough balance-sheet time. If the same combination repeats, negative operating cash flow, Blue Line equity injections, higher short-term credit, and another NIS 40 million distribution, the debate will move from whether the company has backlog to how much of that backlog is being financed at the expense of shareholder flexibility. Q1 gave the company another bridge period, not an exemption from the cash test.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.